Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants
Terminated · Phase 2 · NCT05584202
Conditions: SARS-CoV-2
At a glance
- Research payments reported, 2025
- $302,829
- U.S. investigators named
- 28
- Sites paid
- 25
- Planned or actual enrollment
- 68
About the trial
- Sponsor
- ModernaTX, Inc.
- Tested
- mRNA-1273.214 (biological), Placebo (other)
- Dates
- Started 2022-09-30; completion 2024-11-15
- Results posted
- Yes
The study evaluated the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273.214 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in infants aged 12 weeks to \< 6 months.
From ClinicalTrials.gov, last updated 2025-11-26. Full record, eligibility and contacts (opens in a new tab)
Industry funding
ModernaTX, Inc. reported $302,829 in research payments for this study in 2025 (139 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Swetha Geetha Pinninti, M.D Pediatric Infectious Disease · Birmingham, AL
- Amrita K. Dosanjh, M.D. Pediatric Pulmonology · La Jolla, CA
- John M. Hernandez, MD Internal Medicine · Montebello, CA
- Elizabeth Mcfarland, MD Pediatric Infectious Disease · Aurora, CO
- Armando E. Acevedo, M.D. General Practice · Miami, FL
- Teena L. Hughes, M.D. Pediatrics · Tampa, FL
- Mobeen H. Rathore, M.D. Pediatric Infectious Disease · Jacksonville, FL
- Christina A. Rostad, MD Pediatric Infectious Disease · Atlanta, GA
- Michael W. Simon, M.D. Pediatrics · Nicholasville, KY
- Jibran E. Atwi, MD Allergy & Immunology · Lafayette, LA
- William F. Beacham, M.D. OB-GYN (Obstetrics & Gynecology) · Hammond, LA
- Katherine F. Ruiz-de-luzuriaga, M.D. Pediatric Infectious Disease · Worcester, MA
- James D. Campbell, MD Pediatric Infectious Disease · Baltimore, MD
- Gary D. Berman, M.D. Allergy & Immunology · Minneapolis, MN
- Daniel J. Leonard IV, D.O. Pediatrics · Hastings, NE
- Swati A. Johnson, DO Neonatology · Voorhees, NJ
- Leonard B. Weiner, MD Pediatric Infectious Disease · Syracuse, NY
- Judith Martin Specialist · Pittsburgh, PA
- Yvette L. Piovanetti, M.D. Pediatrics · San Juan, PR
- Robert A. Clifford, M.D. Pediatrics · Charleston, SC
- Anthony G. Pruitt, M.D. Pediatrics · Blythewood, SC
- Kashif R. Ali, M.D. Pediatrics · Houston, TX
- John W. Clinton III, M.D. Pediatrics · Port Lavaca, TX
- Wieslaw J. Jakubowski, M.D. Pediatrics · Corpus Christi, TX
- Nathan G. Forbush, M.D. Pediatrics · Layton, UT
- Peter E. Silas, M.D. Pediatrics · Syracuse, UT
- Richard L. Bennett JR., MD Pediatrics · Richmond, VA
- Sofia Teferi, MD Pediatrics · Richmond, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Velocity Clinical Research Inc $50,789
- Seracollection Research Services LLC $39,181
- Alliance for Multispecialty Research LLC $35,985
- Emory University Hospital, GA $33,403
- University of Alabama Hospital, AL $25,837
- The Research Foundation Suny $18,250
- Acevedo Clinical Research Associates Co $16,520
- Tanner Clinic $11,384
- Victoria Clinical Research Group $10,724
- Coastal Pediatric Research $8,990
- Cedar Health Research LLC $8,244
- University of Pittsburgh $7,962
- Children's Hospital Colorado, CO $6,801
- University of Florida Contracts and Grants Accounting Services $5,559
- Pas Research $5,080
- Dynamed Clinical Research LP $3,214
- Suncoast Research Associates LLC $2,661
- South Texas Clinical Research $2,518
- Clinical Research Institute Inc $2,160
- University of Maryland Baltimore $1,950
- University of Massachusetts Medical School $1,801
- Michael W Simon MD Psc $1,793
- Brcr Medical Center Inc $1,250
- Clinical Research of California LLC $550
- Clinical Research PArtners $225
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.